Jun 08, 2022 / 06:00PM GMT
Operator
Good morning, and welcome to the 2022 annual meeting of stockholders of GT Biopharma. Please note that this event is currently being webcasted. I would like to turn the conference over to Michael Breen, our Executive Chairman of the Board and Interim CEO, who will introduce his team. Mr. Breen, please go ahead.
Michael Breen - GT Biopharma, Inc. - Executive Chairman & Interim CEO
Thank you, and good morning. I am Michael Breen, Executive Chairman of the Board and Interim Executive Chief Executive Officer of GT Biopharma, Inc. Joining me today is Manu Ohri, our Chief Financial Officer. On behalf of our Board of Directors and management team, I would like to welcome you to GT Biopharma's 2022 annual shareholders meeting. I will act as Chair for the meeting, and I now call the meeting to order.
We are hosting a virtual meeting of stockholders with those of you attending doing so exclusively via our web portal and by telephone. We believe that through this online platform, we can increase stockholder access and participation. I have before me an
GT Biopharma Inc Annual Shareholders Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
